RxDoctor Payments Data

Jane Maxwell, MD

Psychiatry · Saranac Lake, NYNPI 1467463703

Payments from drug & device makers

$641in general payments, 2019–2025

Across 42 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$151
  • Otsuka America Pharmaceutical, Inc.$99
  • Takeda Pharmaceuticals U.S.A., Inc.$92
  • Johnson & Johnson$78
  • Supernus Pharmaceuticals, Inc.$65
  • Sunovion Pharmaceuticals Inc.$63
  • plus $93 from 6 others

What the payments were for

  • Food & beverage$641100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$641 in reported general payments places this provider in the 70th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$53,419
Medicare patients
141
Services billed
570

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl83$119,481
Invega SustennaPaliperidone Palmitate30$100,378
AustedoDeutetrabenazine26$72,684
Wellbutrin XlBupropion Hcl22$51,241
CaplytaLumateperone Tosylate26$39,914
AristadaAripiprazole Lauroxil18$38,602
Clozapine377$35,378
TrintellixVortioxetine Hydrobromide66$33,738
Lurasidone Hcl141$15,175
FetzimaLevomilnacipran Hcl25$14,320
Divalproex Sodium ErDivalproex Sodium242$11,520
NuedextaDextromethorphan Hbr/Quinidine13$10,584
Divalproex Sodium176$9,670
QelbreeViloxazine Hcl14$8,042
Olanzapine310$7,402

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Fetzima$151$133,801108 claims
Johnson & JohnsonInvega Sustenna$78$100,37830 claims
Teva Pharmaceuticals USA, Inc.Austedo$16$72,68426 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$92$33,73866 claims
Supernus Pharmaceuticals, Inc.Qelbree$65$8,04214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Saranac Lake

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →